K-Dense
K-Dense is an AI co-scientist startup that develops agentic systems to accelerate biomedical discovery and transform scientific analysis, compressing years of research into days.
At a Glance
- Pharmaceuticals
- Venture Capital
- Academic Institutions
- Biotech
AI Tools by K-Dense
(1)
K-Dense Web
AI Agent for Research Analysis
Discussions
No discussions yet
Be the first to start a discussion about K-Dense
Latest News
Products & Services
An AI agent that autonomously executes complex tasks across science, engineering, healthcare, and finance.
A multi-agent AI system designed to accelerate biomedical discovery and understood biological systems.
Towards fully automated scientific analysis, generating publication-ready reports from raw data.
Market Position
Positioned as a specialized AI 'co-scientist' that outperforms general-purpose LLMs in deep scientific synthesis and analysis.
Leadership
Founders
Timothy Kassis, PhD
Co-Founder & CTO at K-Dense. PhD in Bioengineering from MIT. Previously worked on a $25m DARPA-funded project to build complex interacting microphysiological systems.
Ashwin Gopinath
Co-Founder & CEO of K-Dense. Assistant Professor at MIT (Research Laboratory of Electronics). Focus on AI for biology and scientific discovery.
Executive Team
Vinayak Agarwal, PhD
Principal AI Engineer
Expert in AI for longevity and bio-AI. Leading AI engineering efforts for scientific discovery agents.
Orion Li
AI Research Scientist
Lead author on K-Dense Analyst research; focuses on fully automated scientific analysis systems.
Board of Directors
Founding Story
Founded to address the slow pace of scientific discovery by leveraging multi-agent AI systems to automate research, synthesis, and analysis.
Business Model
Revenue Model
Hybrid model combining SaaS subscriptions (Personal/Plus/Team) and pay-as-you-go usage based on effort levels (Fast, Standard, Pro).
Pricing Tiers
Access for individual researchers and enthusiasts.
Advanced features for power users.
Collaborative tools for research groups.
Full-scale autonomous execution with dedicated support.
Target Markets
- Pharmaceuticals
- Venture Capital
- Academic Institutions
- Biotech
- Biomedical discovery
- Venture Capital due diligence
- Academic research
- Scientific analysis
- Financial modeling
- Harvard Longevity Discovery Center